NCT05035966View on ClinicalTrials.gov

Association of β-amyloid 40 and 42 With Prediabetes

CompletedOBSERVATIONAL
Enrollment

1,442

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2020

Conditions
PreDiabetes
Interventions
OTHER

Plasma β-amyloid 40 and 42 concentration

Plasma β-amyloid 40 and 42 concentrations were simultaneously measured by validated assay platforms from Meso Scale Discovery (MSD; Rockville, MD, USA).

All Listed Sponsors
lead

Liegang Liu

OTHER

NCT05035966 - Association of β-amyloid 40 and 42 With Prediabetes | Biotech Hunter | Biotech Hunter